{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:09:26Z","timestamp":1762506566146},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T00:00:00Z","timestamp":1433376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00018-015-1944-9","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T01:33:57Z","timestamp":1433381637000},"page":"4399-4407","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["PI3 kinase is indispensable for oncogenic transformation by the V560D mutant of c-Kit in a kinase-independent manner"],"prefix":"10.1007","volume":"72","author":[{"given":"Oscar","family":"Lindblad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julhash U.","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"R\u00f6nnstrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,4]]},"reference":[{"key":"1944_CR1","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1152\/physrev.00046.2011","volume":"92","author":"J Lennartsson","year":"2012","unstructured":"Lennartsson J, R\u00f6nnstrand L (2012) Stem cell factor receptor\/c-Kit: from basic science to clinical implications. Physiol Rev 92:1619\u20131649. doi: 10.1152\/physrev.00046.2011","journal-title":"Physiol Rev"},{"key":"1944_CR2","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1074\/jbc.M808058200","volume":"284","author":"J Sun","year":"2009","unstructured":"Sun J, Pedersen M, R\u00f6nnstrand L (2009) The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction. J Biol Chem 284:11039\u201311047. doi: 10.1074\/jbc.M808058200","journal-title":"J Biol Chem"},{"key":"1944_CR3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/sj.onc.1203354","volume":"19","author":"F Hayakawa","year":"2000","unstructured":"Hayakawa F, Towatari M, Kiyoi H et al (2000) Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines. Oncogene 19:624\u2013631. doi: 10.1038\/sj.onc.1203354","journal-title":"Oncogene"},{"key":"1944_CR4","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1074\/jbc.M211726200","volume":"278","author":"O Voytyuk","year":"2003","unstructured":"Voytyuk O, Lennartsson J, Mogi A et al (2003) Src family kinases are involved in the differential signaling from two splice forms of c-Kit. J Biol Chem 278:9159\u20139166. doi: 10.1074\/jbc.M211726200","journal-title":"J Biol Chem"},{"key":"1944_CR5","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1038\/onc.2013.479","volume":"33","author":"J Sun","year":"2014","unstructured":"Sun J, Mohlin S, Lundby A et al (2014) The PI3-kinase isoform p110delta is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner. Oncogene 33:5360\u20135369. doi: 10.1038\/onc.2013.479","journal-title":"Oncogene"},{"key":"1944_CR6","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1002\/j.1460-2075.1993.tb06104.x","volume":"12","author":"P Blume-Jensen","year":"1993","unstructured":"Blume-Jensen P, Siegbahn A, Stabel S, Heldin CH, R\u00f6nnstrand L (1993) Increased Kit\/SCF receptor induced mitogenicity but abolished cell motility after inhibition of protein kinase C. EMBO J 12:4199\u20134209","journal-title":"EMBO J"},{"key":"1944_CR7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.exphem.2013.03.005","volume":"41","author":"JU Kazi","year":"2013","unstructured":"Kazi JU, Sun J, R\u00f6nnstrand L (2013) The presence or absence of IL-3 during long-term culture of Flt3-ITD and c-Kit-D816V expressing Ba\/F3 cells influences signaling outcome. Exp Hematol 41:585\u2013587. doi: 10.1016\/j.exphem.2013.03.005","journal-title":"Exp Hematol"},{"key":"1944_CR8","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1002\/j.1460-2075.1996.tb00915.x","volume":"15","author":"K Hansen","year":"1996","unstructured":"Hansen K, Johnell M, Siegbahn A et al (1996) Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis. EMBO J 15:5299\u20135313","journal-title":"EMBO J"},{"key":"1944_CR9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/373536a0","volume":"373","author":"Z Songyang","year":"1995","unstructured":"Songyang Z, Carraway KL 3rd, Eck MJ et al (1995) Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536\u2013539. doi: 10.1038\/373536a0","journal-title":"Nature"},{"issue":"Suppl 1","key":"1944_CR10","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1007\/s00280-010-1526-3","volume":"67","author":"MM Gounder","year":"2011","unstructured":"Gounder MM, Maki RG (2011) Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor. Cancer Chemother Pharmacol 67(Suppl 1):S25\u2013S43. doi: 10.1007\/s00280-010-1526-3","journal-title":"Cancer Chemother Pharmacol"},{"key":"1944_CR11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.molonc.2012.10.008","volume":"7","author":"S Brahimi-Adouane","year":"2013","unstructured":"Brahimi-Adouane S, Bachet JB, Tabone-Eglinger S et al (2013) Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KIT. Mol Oncol 7:323\u2013333. doi: 10.1016\/j.molonc.2012.10.008","journal-title":"Mol Oncol"},{"key":"1944_CR12","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1038\/sj.onc.1202929","volume":"18","author":"J Lennartsson","year":"1999","unstructured":"Lennartsson J, Blume-Jensen P, Hermanson M, Pont\u00e9n E, Carlberg M, R\u00f6nnstrand L (1999) Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor\/c-kit mediated activation of the Ras\/MAP kinase pathway and c-fos induction. Oncogene 18:5546\u20135553. doi: 10.1038\/sj.onc.1202929","journal-title":"Oncogene"},{"issue":"Pt 1","key":"1944_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/bj3410211","volume":"341","author":"K Th\u00f6mmes","year":"1999","unstructured":"Th\u00f6mmes K, Lennartsson J, Carlberg M, R\u00f6nnstrand L (1999) Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit\/stem cell factor receptor. Biochem J 341(Pt 1):211\u2013216","journal-title":"Biochem J"},{"key":"1944_CR14","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.1016\/S0021-9258(17)37564-6","volume":"269","author":"H Serve","year":"1994","unstructured":"Serve H, Hsu YC, Besmer P (1994) Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells. J Biol Chem 269:6026\u20136030","journal-title":"J Biol Chem"},{"key":"1944_CR15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1158\/1541-7786.MCR-12-0352","volume":"10","author":"SJ Adams","year":"2012","unstructured":"Adams SJ, Aydin IT, Celebi JT (2012) GAB2\u2014a scaffolding protein in cancer. Mol Cancer Res 10:1265\u20131270. doi: 10.1158\/1541-7786.MCR-12-0352","journal-title":"Mol Cancer Res"},{"key":"1944_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20120769","volume":"447","author":"MK Wills","year":"2012","unstructured":"Wills MK, Jones N (2012) Teaching an old dogma new tricks: twenty years of Shc adaptor signalling. Biochem J 447:1\u201316. doi: 10.1042\/BJ20120769","journal-title":"Biochem J"},{"key":"1944_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0065-230X(10)06002-1","volume":"106","author":"KS Grossmann","year":"2010","unstructured":"Grossmann KS, Rosario M, Birchmeier C, Birchmeier W (2010) The tyrosine phosphatase Shp2 in development and cancer. Adv Cancer Res 106:53\u201389. doi: 10.1016\/S0065-230X(10)06002-1","journal-title":"Adv Cancer Res"},{"key":"1944_CR18","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood-2002-01-0177","volume":"101","author":"K Hashimoto","year":"2003","unstructured":"Hashimoto K, Matsumura I, Tsujimura T et al (2003) Necessity of tyrosine 719 and phosphatidylinositol 3\u2032-kinase-mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine kinase with the Asp814Val mutation. Blood 101:1094\u20131102. doi: 10.1182\/blood-2002-01-0177","journal-title":"Blood"},{"key":"1944_CR19","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/j.1460-2075.1992.tb05426.x","volume":"11","author":"JM Backer","year":"1992","unstructured":"Backer JM, Myers MG Jr, Shoelson SE et al (1992) Phosphatidylinositol 3\u2032-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11:3469\u20133479","journal-title":"EMBO J"},{"key":"1944_CR20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc3143","volume":"11","author":"CL Corless","year":"2011","unstructured":"Corless CL, Barnett CM, Heinrich MC (2011) Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer 11:865\u2013878. doi: 10.1038\/nrc3143","journal-title":"Nat Rev Cancer"},{"key":"1944_CR21","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1073\/pnas.0812413106","volume":"106","author":"KS Gajiwala","year":"2009","unstructured":"Gajiwala KS, Wu JC, Christensen J et al (2009) KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients. Proc Natl Acad Sci USA 106:1542\u20131547. doi: 10.1073\/pnas.0812413106","journal-title":"Proc Natl Acad Sci USA"},{"key":"1944_CR22","doi-asserted-by":"crossref","first-page":"31655","DOI":"10.1074\/jbc.M403319200","volume":"279","author":"CD Mol","year":"2004","unstructured":"Mol CD, Dougan DR, Schneider TR et al (2004) Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase. J Biol Chem 279:31655\u201331663. doi: 10.1074\/jbc.M403319200","journal-title":"J Biol Chem"},{"key":"1944_CR23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jmgm.2004.04.003","volume":"23","author":"R Foster","year":"2004","unstructured":"Foster R, Griffith R, Ferrao P, Ashman L (2004) Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tyrosine kinase. J Mol Gr Model 23:139\u2013152. doi: 10.1016\/j.jmgm.2004.04.003","journal-title":"J Mol Gr Model"},{"key":"1944_CR24","first-page":"2463","volume":"32","author":"JE Kurtz","year":"2012","unstructured":"Kurtz JE, Ray-Coquard I (2012) PI3 kinase inhibitors in the clinic: an update. Anticancer Res 32:2463\u20132470","journal-title":"Anticancer Res"},{"key":"1944_CR25","doi-asserted-by":"crossref","first-page":"27444","DOI":"10.1074\/jbc.M709703200","volume":"283","author":"J Sun","year":"2008","unstructured":"Sun J, Pedersen M, R\u00f6nnstrand L (2008) Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit. J Biol Chem 283:27444\u201327451. doi: 10.1074\/jbc.M709703200","journal-title":"J Biol Chem"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-015-1944-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-015-1944-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-015-1944-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T22:13:20Z","timestamp":1652220800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-015-1944-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,4]]},"references-count":25,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["1944"],"URL":"https:\/\/doi.org\/10.1007\/s00018-015-1944-9","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,4]]}}}